Cabaletta Bio (CABA) Treasury Shares (2018 - 2019)
Cabaletta Bio (CABA) posted quarterly Treasury Shares of $19.4 million for Q3 2019, little changed quarter-over-quarter from $19.4 million in Q2 2019.
Powered by 
Analysis
Cabaletta Bio (CABA) Treasury Shares (2018 - 2019) Analysis & Trends
Cabaletta Bio's Treasury Shares history runs 2 years deep, the most recent figure standing at $19.4 million for Q3 2019.
- In Q3 2019, Treasury Shares changed N/A year-over-year to $19.4 million; the TTM figure through Sep 2019 stood at $19.4 million (changed N/A YoY), while the FY2018 annual figure was $7.4 million, changed N/A from the prior year.
- Treasury Shares for Q3 2019 stood at $19.4 million, roughly flat from $19.4 million in the prior quarter.
- The five-year high for Treasury Shares was $19.4 million in Q1 2019, with the low at $7.4 million in Q4 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 2.72 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Cabaletta Bio | 522.26 Mn | 522.26 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2019 | 19.36 Mn |
| Sep 30, 2019 | 19.36 Mn |
| Jun 30, 2019 | 19.36 Mn |
| Jun 30, 2019 | 19.36 Mn |
| Mar 31, 2019 | 19.36 Mn |
| Mar 31, 2019 | 19.36 Mn |
| Dec 31, 2018 | 12.39 Mn |
| Dec 31, 2018 | 12.39 Mn |